Excited to be a faculty participant for the 14th Annual Asia-Pacific Primary Liver Cancer Expert Meeting! Ghassan Abou-Alfa #HCC #APPLE PER
📌Collaborate, learn, and share the latest advancements and findings in the field of liver cancer with distinguished scholars and…

Superb presentation and discussion of Layal Al Mahmasani at the Memorial Sloan Kettering Cancer Center MSK Department of Medicine Monthly Global GI Fellows #GGF meeting. Thanks Leonard Saltz and Viktoriya Paroder MD PHD FSAR for the valuable discussion.

Years, not months. Memorial Sloan Kettering Cancer Center MSK Department of Medicine Ghassan Abou-Alfa present collaborative efforts of Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable #HCC in Annals of Oncology annalsofoncology.org/article/S0923-…

Throwback to 2013! Honored then by a visit to Faculty of Medicine Division of Nephrology & Hypertension by the late Dr Edmund Shwayri, pioneer nephrologist & Chairperson of the Department of Internal Medicine, flanked by my 3 predecessor chairpersons Samir Atweh, Kamal Badr & Fuad Ziyadeh.

CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular #carcinoma , by Ghassan Abou-Alfa et al.
bit.ly/3Ihqzw3
Memorial Sloan Kettering Cancer Center #openaccess

Congratulations for all Soraya Fares Abou-Alfa girl high-school students and thank you for your green thumbs! Our mother your role model will sure be proud of you! ⁦Ghassan Abou-Alfa⁩ ⁦Ali Abu-Alfa⁩ ⁦Amer K. Abu Alfa, M.D.⁩ ⁦Eileen M O’Reilly⁩ facebook.com/10006661969277…

'I am honored to represent the International Society of Nephrology and its Renal Disaster Preparedness Working Group (RDPWG) at this important global meeting. My colleagues and I, on behalf of the ISN, are most grateful to World Health Organization (WHO)-@refugees for the invitation to hold a side event on…

🎥Ghassan Abou-Alfa from Memorial Sloan Kettering Cancer Center presents infigratinib as a potential frontline treatment for FGFR2 gene fusion in cholangiocarcinoma. Despite trial halt, preliminary results show promising efficacy with higher response rate. 🩺

➡️ow.ly/zZ4p50QInCJ⬅️

#GI24 #CTSM

In Annals of Oncology, B. Sangro Ghassan Abou-Alfa and coll. report #OpenAccess on the 4-year overall survival update from the study

annalsofoncology.org/article/S0923-…

2/2

Contrary to what we thought Memorial Sloan Kettering Cancer Center MSK Department of Medicine Ghassan Abou-Alfa and colleagues conclude no clear impact association between #hepatitis C and sorafenib in patients with #HCC . It is even confusing pubmed.ncbi.nlm.nih.gov/38363156/

Congratulations and thank you Layal Al Mahmasani on a superb leadership of the Memorial Sloan Kettering Cancer Center MSK Department of Medicine Monhtly #MSKGIOncologyFellowsVirtualMeeting . Thank you Autumn Guyer Leonard Saltz Viktoriya Paroder MD PHD FSAR for valuabale discussion. See you all next March 13!

Don't miss your chance to join this incredible faculty lineup on March 8-11 for a comprehensive #Hematology and #MedicalOncology Update & #BoardReview Memorial Sloan Kettering Cancer Center #MSKHemOncCME

View the complete program or register at bit.ly/HemOnc2024

American University of Beirut Maingate 1912

Not sure where Toni Choueiri, MD will be staying. You have time to decide!

Two years ago today, President Biden and Jill Biden convened the cancer community in the East Room of the White House and committed to supercharge the #BidenCancerMoonshot .

Since then, we have made incredible progress — and together, we will end cancer as we know it.
whitehouse.gov/ostp/news-upda…

Congratulations Memorial Sloan Kettering Cancer Center MSK Department of Medicine American University of Beirut Hikmat Al Ahmadie and all dear colleagues on an impressive collaborative work. More to come

This is such a big honor!!! I am enormously humbled and grateful 💜

10 women in STEM - pick it up and keep it moving Dr. Nina Steele Débora Vendramini-Costa, Ph.D PascaLab Zobeida Cruz-Monserrate Ph.D. Kathy Del-dorko Mara Sherman Lab Rushika M. Perera Ruth Shouval Kailee Keke Fairfax, PhD

Happening now at an ASCO
#GI24 poster session: Memorial Sloan Kettering Cancer Center's Eileen M O’Reilly is presenting phase 1 results of a novel sialyl Lewis A-targeting monoclonal antibody alone and in combination with mFOLFIRINOX in patients with CA19-9 expressing #cancers .

It was wonderful to catch up with Ghassan Abou-Alfa from
Memorial Sloan Kettering Cancer Center who discussed all things #Cholangiocarcinoma including key learnings from the PROOF 301 study as well as the landscape of personalized treatment strategies

ASCO #GI24 #CCA #GIsm